- It's unclear would could persuade me to vote to cut rates
Most Popular
Sponsored
UPST beats revenue but misses EPS. High costs hit profit, but AI models drive originations. Valuation at $2.75B.
RoboForex, HFM, FXTM offer transparency & insurance. Trust built on longevity, strict regulation, and clear pricing.
HSIC beats EPS, revenue estimates on U.S. dental strength. Margins face oil price risk.
Magnificent Seven surge $4.8T since April, but concentration risks loom for S&P 500 & Nasdaq-100.
IART beats EPS estimates by 33%, raises guidance. Margin up on mix & lower costs. Buy?
Champlain exits $125M FRPT stake. Stock down 36% YOY, trades at 13x EBITDA. Potential value play?
CHRD beats earnings, but margins dip on costs. Stock down despite oil volume gains. Buy signal?
Sponsored
Must Read